Members

Approved

GaiverGamma GaiverGamma

Approved

angelinatp4 angelinatp4

Approved

Glenford Robinson

Fintech
Benzinga BioTech
Investment News
Stocks to Watch
Finance
Most Popular News Articles
Bitcoin News
Cramers Picks
Technology News
Stocks and Commodities
Daily Technical Analysis
CGC
Featured Stock
Emerging Markets
Economy
Investing
Options
Real Estate News
Nasdaq Stock News
Latest Articles in Real Estate
Mstardom Finance
Food and Drug Administration--Press Releases
What's New: Drugs RSS Feed
OTC Markets Group - News, Filings & Corporate Actions
ECB - European Central Bank
FRB: Press Release - All Releases
Press Releases
St. Louis Fed - Recent Research
Research Announcements – St. Louis Fed Economic Research
Economic Education
Investor Alerts and Bulletins
SEC.gov Updates: Litigation Releases
SEC.gov Updates: Proposed Rules

Cashfree has Built Modern Mobile Payment App With Local Shoppers in Mind

20 February 2019 - PRNewswire

GHENT, Belgium, Feb. 20, 2019 /PRNewswire/ -- Cashfree is a mobile payment ...

Full story available on Benzinga.com

The Daily Biotech Pulse: Teva Settles With FTC, Setback For Merck In Liver Cancer Trial, Sienna Biopharma Offering

20 February 2019 - Shanthi Rexaline

Here's a roundup of top developments in the biotech space over the last 24 hours:

Scaling The Peaks

(Biotech stocks hitting 52-week highs on Feb. 19)

Alector Inc (NASDAQ: ALEC) (IPOed early February) Avedro Inc (NASDAQ: AVDR)(debuted Tuesday) BioDelivery Sciences International, Inc. (NASDAQ: BDSI) Eton Pharmaceuticals Inc (NASDAQ: ETON)( announced an agreement with Bausch Health Companies Inc (NYSE: BHC) to sell U.S. rights to its investigational eye drops EM-100) NxStage Medical, Inc. (NASDAQ: NXTM) Orthofix Medical Inc (NASDAQ: OFIX) PDL BioPharma Inc (NASDAQ: PDLI) Synthorx Inc (NASDAQ: THOR) Down In The Dumps

(Biotech stocks hitting 52-week lows on Feb. 19)

Chimerix Inc (NASDAQ: CMRX) MOTIF BIO PLC/S ADR (NASDAQ: MTFB)(announced an amended agreement with its lender Hercules Capital, which provides for immediate early repayment of $7 million and a $0.5 million repayment on the earlier of 90 days, being May 18, or receipt of funds from an equity raise of $2 million or greater) Stock In Focus Merck's Keytruda Fails In Late-stage Trial For Liver Cancer

Merck & Co., Inc. (NYSE: MRK) said a pivotal Phase 3 study dubbed KEYNOTE-240 that uated its anti-PD-1 therapy Keytruda plus best supportive care for advanced hepatocellular carcinoma in patients, who were previously treated with systemic therapy, did not meet its co-primary endpoints of overall survival and progression-free survival compared with placebo plus best supportive care.

The stock slipped 1.11 percent to $78.36 in after-hours trading.

Novartis' Sandoz Unit Announces U.S. Launch of Generic Drug to Treat Opioid Dependence

Novartis AG (NYSE: NVS) said its generic unit Sandoz has launched ...

Full story available on Benzinga.com

Hedging vs. Speculation: The Main Differences

20 February 2019

Hedging and speculation are very different in purpose, function and risk profile. Find out how and why investors use both.

Stocks to Watch: DuPont, Nike, KB Home are stocks to watch

27 June 2014

Among the companies whose shares are expected to see active trade in Friday’s session are DuPont, Nike, and KB Home.

PagSeguro Earnings Preview: Short-Term Missteps Need Support From Long-Term Trends

20 February 2019

This Never Happened In The 1974, 2001, And 2008 Bear Markets

20 February 2019

Judge Appoints 2 Law Firms to Represent Quadrigacx Clients

20 February 2019 - Lubomir Tassev

Judge Appoints 2 Law Firms to Represent Quadrigacx Clients Two law firms have been appointed to represent the clients of insolvent Canadian crypto exchange Quadrigacx in court. The number of affected users has been estimated at approximately 115,000 and lawyers will have to contact as many as they can. The digital asset trading platform owes them approximately $190 million. Also read: Hacked NZ Exchange […]

The post Judge Appoints 2 Law Firms to Represent Quadrigacx Clients appeared first on Bitcoin News.

Long-Term Growth Stocks - Cramer's Mad Money (12/11/18)

12 December 2018

Lose yourself in the music and save 40% off Plantronics BackBeat PRO 2 wireless headphones at Amazon

20 February 2019 - Ryan Lakich

No matter where you go, there's just too much noise to enjoy your music or podcast in peace. There's always a loud subway, crying baby on a plane, or a coworker in an open office plan who only eats crunchy snacks. A good pair of noise canceling headphones will take you to your happy place, and now you can get 40% off a pair of Plantronics BackBeat PRO 2 wireless headphones at Amazon.

For a limited time, a new pair of Plantronics BackBeat PRO 2 headphones will only cost you $119.99. That's $79 off the normal price, and a good deal cheaper than comparable over-hear wireless headphones such as the Beats Studio3 or Sennheiser PXC 550. If your budget for wireless headphones is less than $200, the BackBeat PRO 2 at this price easily beats similar options without sacrificing audio quality and other special features. Read more...

More about Headphones, Wireless Headphones, Noise Canceling Headphones, Plantronics, and Mashable Shopping

OIL targets update

20 February 2019

Oil reached the upside weekly target

Crypto - Summer Is Coming!

19 February 2019

Hello everyone! It looks like the boring market is going to become a little bit interesting. Which benefits can we get from such transformation? Will it be long term changes? Let's try to figure it out. I want to start from the following. We got two big bullish candles which were formed 08.02 and 18.02 and small candles around them. It can be a signal of coming interest to BTC and that probably big players start building long term positions. The market did not drop after upward movements and it just confirms that these positions were opened not for short term profits. Another interesting and important fact, not only BTC but also altcoins made a good upward movement. It's another positive moment confirming interest to crypto. Now it's rather difficult to say, what was the real reason for such movement. But we can use this movement as a bullish signal. The next question is - should we expect a new uptrend? Now we have the bearish market, the correction movement which was realized in a sideways movement. For starting a new uptrend, we have to get confirmation that the downtrend is over and we must get signals confirming the trend reversal. You can use different tools for this and I use Moving Average with 100 period. For me, it's the line of the main long term trade which I follow. If the price is below this line - we have a bearish market. If the price is above the line - we have a bullish market. The breakouts above/below this line confirm trend reversals. If we look at BTC, we can see that the price tries to break the resistance zone formed by SMA100 and 4000.00 psychologically important level. It tells us that the downtrend is going to be reversed. Will we get a new uptrend after that of a new sideways movement, we will see later. Now we have to use only this signal confirming changes in the bearish market. If we look at indicators, they also give bullish signals. MACD lines and histogram support further upward movement. RSI confirms the strength of buyers. DMI is bullish and confirms trend market conditions. ADX lines move upward, and it gives a signal that bulls become stronger. When the market makes a new swing high, makes a retracement after that and forms a new swing low - only after that, we will be able to tell about a new uptrend. If the market can stay above 3500.00 support and start a new upward movement from this zone, it will be a good confirmation for starting the bullish period. As a variant, the price can drop below 3500.00 but bounce from the uptrend line - in such way we also will have confirmation for the uptrend. The only breakout below the new uptrend line will be a signal that bears have control under BTC and crypto. But for such falling, there must be solid fundamental reasons. Concluding, we have to become positive with BTC and crypto as a whole. Good signals are confirming that buyers become more active and it can lead to starting the new uptrend. Will BTC be able to develop the good upward movement in the solid uptrend, we will see. For this, we will have to get new signals showing the zones of reversal after the retracement, and how active buyers will be in such period. I remind you that it's just my vision about possible market movements. If you have your own, please share in comments. I will be glad to discuss with you. I will be very grateful for supporting my post by your LIKEs, if it's not so hard for you.

CGC triangle formation

19 February 2019

There is no stopping the weed train, at least in the Canada's 9 billion weed market. CGC went from $20's in dec to $50 this month. And I can see a triangle formation on chart. Maybe a breakout in upper 50's next week?

Breaking out here

20 February 2019

Strong open!

4 Marijuana Stocks to Watch in 2019

19 February 2019

Marijuana stocks may not have had a stellar year in 2018 160 160 But this year could easily bring better news as things continue to expand and more new marijuana markets open up Canada became the first country to legalize recreational weed last October This development has

Wall Street points to higher open; Dow futures jump 200 points

22 February 2016

Investing.com Investing.com U.S. stock markets pointed to strong gains at the open on Monday, with the Dow futures briefly jumping more than 200 points as a rebound in oil prices boosted market sentiment. The blue chip Dow futures climbed

Walmart & Medtronic Report Earnings

19 February 2019

To kick off a shortened week due to Presidents Day Monday we see a much lighter calendar both in economic data and Q4 earnings releases Aside from a report on the February Home Builders Index due after the opening bell and a few key earnings reports so far this morning we re notably

MGP Ingredients Shares Cross Above 200 DMA

19 February 2019

In trading on Tuesday shares of MGP Ingredients Inc Symbol MGPI crossed above their 200 day moving average of 76 66 changing hands as high as 77 83 per share MGP Ingredients Inc shares are currently trading up about 1 8 on the day The chart below shows the one year performance of

Bullish Two Hundred Day Moving Average Cross - ZION

19 February 2019

In trading on Tuesday shares of Zions Bancorporation N A Symbol ZION crossed above their 200 day moving average of 50 62 changing hands as high as 50 86 per share Zions Bancorporation N A shares are currently trading up about 1 2 on the day The chart below shows the one

Google Buys Another Cloud Migration Startup

20 February 2019

Last May Alphabet NASDAQ GOOG NASDAQ GOOGL subsidiary Google bought Israel based Velostrata as part of its efforts to make enterprise cloud migration easier The search giant announced 160 today that it is now acquiring another cloud migration company Alooma Google says

U.S. Home Sales are Plummeting And Nobody's Sure Why

30 January 2019

The U.S. housing market is crumbling--a worrying indication that an economic catastrophe could be brewing. Yet, nobody seems sure why this is happening in an economy that remains hale and hearty by most measures. But don’t rush to your banker just yet hoping to get an easy deal. Rejections for mortgages and

SEC Files Charges in Elaborate Microcap Stock Fraud

18 February 2019 - Glenford Robinson

“As alleged in our complaint, Magna Group and its co-defendants used fake debt instruments to unlawfully obtain shares in microcap companies, which they then dumped on unsuspecting retail investors,” said Sanjay Wadhwa, Senior Associate Director of the SEC’s New York Regional Office. “This action demonstrates the resolve of the SEC in pursuing fraudsters who use elaborate financing schemes to engage in securities fraud.”

Statement from FDA Commissioner Scott Gottlieb, M.D., and Director of FDA’s Center for Biologics Evaluation and Research Peter Marks, M.D., Ph.D., cautioning consumers against receiving young donor plasma infusions that are promoted as unproven treatment for varying conditions

19 February 2019

FDA statement cautioning consumers against receiving young donor plasma infusions that are promoted as unproven treatment for varying conditions

Drugs@FDA Download File (new structure)

19 February 2019

Drugs@FDA Data files updated weekly

Findit, Inc. (FDIT: Pink Current) | Joining Findit Helps You Diversify Your Social Networking Accounts So You Engage As Many People As Possible

20 February 2019

Peter Praet: Economic situation and outlook

20 February 2019

Agencies extend comment period on proposed standardized approach for calculating the exposure amount of derivative contracts

15 February 2019

Agencies extend comment period on proposed standardized approach for calculating the exposure amount of derivative contracts

Company Settles Unregistered ICO Charges After Self-Reporting to SEC

20 February 2019

The Securities and Exchange Commission today charged Gladius Network LLC with conducting an unregistered initial coin offering (ICO), which the company self-reported to the SEC.

According to the SEC’s order, Gladius conducted an ICO in late 2017, after the Commission had warned in its DAO Report of Investigation that ICOs can be securities offerings. Gladius, a Washington, DC-based company, raised approximately $12.7 million in digital assets to finance its plan to develop a network for renting spare computer bandwidth to defend against cyberattacks and enhance delivery speed. Gladius did not register its ICO under the federal securities laws, and the ICO did not qualify for an exemption from registration requirements.

Gladius self-reported to the SEC’s Enforcement staff in the summer of 2018, expressed an interest in taking prompt remedial steps, and cooperated with the investigation. The SEC did not impose a penalty because the company self-reported the conduct, agreed to compensate investors, and will register the tokens as a class of securities. The case follows the Commission’s two recent ICO registration cases, in which companies agreed to pay penalties for similar registration violations and agreed to similar undertakings.

“The SEC has been clear that companies must comply with the securities laws when issuing digital tokens that are securities,” said Robert A. Cohen, Chief of the SEC’s Cyber Unit. “Today’s case shows the benefit of self-reporting and taking proactive steps to remediate unregistered offerings.”

Pursuant to the order, Gladius undertakes to return funds to those investors who purchased tokens in the ICO and request a return of funds, and register its tokens as securities pursuant to the Securities Exchange Act of 1934. Gladius also will file required periodic reports with the Commission. Gladius consented to the order without admitting or denying the findings.

The investigation was conducted by Laura K. D’Allaird and Marc E. Johnson of the Enforcement Division’s Cyber Unit and was supervised by Mr. Cohen.

Gauging Market Responses to Monetary Policy Communication

14 February 2019

By Kevin L. Kliesen, Brian Levine, Christopher J. Waller in Review.

Chinese Royalties

8 February 2019

Read up on what China pays to use U.S. intellectual property.

2019 AP Economics Conference

12 July 2019

Are you a seasoned AP economics instructor, new to teaching AP econ courses, or simply contemplating teaching them? If so, join us as Federal Reserve economists, AP economics exam readers, exam developers and instructors, and St. Louis Fed economic education staff present a program packed with the information you need to be successful.

Investor Bulletin: 10 Investment Tips for 2019

12 February 2019

Whether you are a first-time investor or have been investing for years, here are 10 tips from the SEC’s Office of Investor Education and Advocacy to help you in 2019.

Brian Hirsch et al.

15 February 2019

Settlement Concluded with Broker in Case Alleging Public Offering Allocation Fraudulent Practices

Solicitations of Interest Prior to a Registered Public Offering

19 February 2019

SEC Files Charges in Elaborate Microcap Stock Fraud

Investor Alert and Bulletin From SEC Office of Investor Education and Advocacy

Know how to be a better investor.
Did you know that active trading and some other very common investing behaviors actually can undermine investment performance? According to researchers, other common investing mistakes include focusing on past performance, favoring investments from your own country, region, state, or company, and holding on to losing investments too long and selling winning investments too soon.

COURT ORDERS $1 BILLION JUDGMENT AGAINST OPERATORS OF WOODBRIDGE PONZI SCHEME TARGETING RETAIL INVESTORS

“This resolution accomplishes one of the SEC’s core missions to protect retail investors,” said Stephanie Avakian, Co-Director of the SEC’s Division of Enforcement. “Mr. Shapiro and other defendants will be held accountable and required to pay substantial penalties for their misconduct.”

“Our complaint charged that when Woodbridge’s fictitious business model collapsed, the company stopped paying investors and filed for Chapter 11 bankruptcy protection,” said Eric I. Bustillo, Director of the SEC’s Miami Regional Office. “The settlement provides for the return of significant funds to investors.”

SEC Charges Cognizant and Two Former Executives With FCPA Violations

“Bribery to further corporate goals is an illusory path to long-term success. While always the wrong choice, it is particularly egregious when senior executives chart that course for those they lead, as our complaint alleges here. We are committed to holding them accountable for their actions,” said Charles E. Cain, Chief of the SEC Enforcement Division’s FCPA Unit.

FDA Authorizes First Interoperable Insulin Pump Intended to Allow Patients to Customize Treatment Through their Individual Diabetes Management Devices

“Diabetes is a complicated disease that requires close monitoring and carefully tailored treatments. We’ve heard from the patient community that having the ability to customize their own diabetes management devices is important to them. Advances in digital health make more tailored approaches to diabetes care possible,” said FDA Commissioner Scott Gottlieb, M.D. “The marketing authorization of the first ACE insulin pump intended for interoperable use has the potential to aid patients who seek more individualized diabetes therapy systems and opens the door for developers of future connected diabetes devices to get other safe and effective products to patients more efficiently. Because the FDA’s action creates a new regulatory classification, future ACE insulin pumps will be able to go through the more efficient 510(k) review process, helping to advance this innovative technology. We’re committed to advancing new ways to accelerate the development of innovations that can improve patient care while strengthening our pre- and post-market tools for determining the safety and effectiveness of these new technologies.

Mstardom Finance Empowering the Investing and Trading Community!

Members

Like this:

Members

Share:

Like this: